Consumption of polyphenol-rich peach and plum juice prevents risk factors for obesity-related metabolic disorders and cardiovascular disease in Zucker rats

Journal of Nutritional Biochemistry

Volumn 26, Issue 6, 2015, Pages 633-641

  Noratto, Giuliana ^a,c,d   Martino, Hercia S D ^b   Simbo, Sunday ^c   Byrne, David ^c   Mertens Talcott, Susanne U ^c,d  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^c TEXAS A AND M UNIVERSITY   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Cardiovascular risk; Metabolic syndrome; Obesity; Peach; Plum; PPAR

Indexed keywords

ANGIOTENSIN II; BIOCHEMICAL MARKER; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; LEPTIN; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYPHENOL; ANGIOTENSIN 1 RECEPTOR; BIOLOGICAL MARKER; CCL2 PROTEIN, RAT; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; FOOD INTAKE; FRUIT JUICE; HYPERGLYCEMIA; INFLAMMATION; MALE; METABOLIC DISORDER; NONHUMAN; OBESITY; PEACH; PLUM; PROTEIN EXPRESSION; RAT; RISK FACTOR; WEIGHT GAIN; ZUCKER FATTY RAT; ZUCKER LEAN RAT; AGONISTS; ANIMAL; BLOOD; CARDIOVASCULAR DISEASES; CHEMISTRY; COMPLICATION; FRUIT AND VEGETABLE JUICE; METABOLIC SYNDROME X; METABOLISM; ZUCKER RAT;

PRUNUS DOMESTICA; PRUNUS PERSICA; RATTUS;

ANGIOTENSIN II; ANIMALS; BIOMARKERS; CARDIOVASCULAR DISEASES; CHEMOKINE CCL2; FRUIT AND VEGETABLE JUICES; INSULIN; INTERCELLULAR ADHESION MOLECULE-1; LEPTIN; MALE; METABOLIC SYNDROME X; NF-KAPPA B; OBESITY; POLYPHENOLS; PPAR GAMMA; PRUNUS DOMESTICA; PRUNUS PERSICA; RATS; RATS, ZUCKER; RECEPTOR, ANGIOTENSIN, TYPE 1; RISK FACTORS; RNA, MESSENGER; WEIGHT GAIN;

EID: 84928928031     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2014.12.014     Document Type: Article

References (78)

1. Gallagher E.J., Leroith D., Karnieli E. Insulin resistance in obesity as the underlying cause for the metabolic syndrome. Mt Sinai J Med 2010, 77:511-523.
2. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
3. Ogunbode A.M., Ladipo M., Ajayi I.O., Fatiregun A.A. Obesity: an emerging disease. Niger J Clin Pract 2011, 14:390-394.
4. Metabolic syndrome 2012, MedlinePlus, U.S. Department of Health and Human Services National Institutes of Health, Bethesda, MD. Medicine USNLo (Ed.).
5. Lago R., Gomez R., Lago F., Gomez-Reino J., Gualillo O. Leptin beyond body weight regulation - current concepts concerning its role in immune function and inflammation. Cell Immunol 2008, 252:139-145.
6. Bastard J.P., Maachi M., Lagathu C., Kim M.J., Caron M., Vidal H., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006, 17:4-12.
7. Kotsis V., Stabouli S., Papakatsika S., Rizos Z., Parati G. Mechanisms of obesity-induced hypertension. Hypertens Res 2010, 33:386-393.
8. Jellinger P.S. Metabolic consequences of hyperglycemia and insulin resistance. Clin Cornerstone 2007, 8(Suppl. 7):S30-S42.
9. Niswender K.D. Basal insulin: beyond glycemia. Postgrad Med 2011, 123:27-37.
10. Holvoet P. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verh K Acad Geneeskd Belg 2008, 70:193-219.
11. Manrique C., Lastra G., Gardner M., Sowers J.R. The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress. Med Clin North Am 2009, 93:569-582.
12. Weir M.R., Dzau V.J. The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens 1999, 12:205S-213S.
13. Guang C., Phillips R.D. Plant food-derived angiotensin I converting enzyme inhibitory peptides. J Agric Food Chem 2009, 57:5113-5120.
14. Higuchi S., Ohtsu H., Suzuki H., Shirai H., Frank G.D., Eguchi S. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology. Clin Sci (Lond) 2007, 112:417-428.
15. Sugawara A., Uruno A., Kudo M., Matsuda K., Yang C.W., Ito S. Effects of PPARgamma on hypertension, atherosclerosis, and chronic kidney disease. Endocr J 2010, 57:847-852.
16. Sugawara A., Uruno A., Kudo M., Matsuda K., Yang C.W., Ito S. PPARgamma agonist beyond glucose lowering effect. Korean J Intern Med 2011, 26:19-24.
17. Horiuchi M., Iwanami J., Mogi M. Regulation of angiotensin II receptors beyond the classical pathway. Clin Sci (Lond) 2012, 123:193-203.
18. Zoechling A., Liebner F., Jungbauer A. Red wine: a source of potent ligands for peroxisome proliferator-activated receptor gamma. Food Funct 2011, 2:28-38.
19. Shin D.W., Kim S.N., Lee S.M., Lee W., Song M.J., Park S.M., et al. (-)-Catechin promotes adipocyte differentiation in human bone marrow mesenchymal stem cells through PPAR gamma transactivation. Biochem Pharmacol 2009, 77:125-133.
20. Xia M., Hou M., Zhu H., Ma J., Tang Z., Wang Q., et al. Anthocyanins induce cholesterol efflux from mouse peritoneal macrophages: the role of the peroxisome proliferator-activated receptor {gamma}-liver X receptor {alpha}-ABCA1 pathway. J Biol Chem 2005, 280:36792-36801.
21. Scazzocchio B., Vari R., Filesi C., D'Archivio M., Santangelo C., Giovannini C., et al. Cyanidin-3-O-beta-glucoside and protocatechuic acid exert insulin-like effects by upregulating PPARgamma activity in human omental adipocytes. Diabetes 2011, 60:2234-2244.
22. Demarin V., Lisak M., Morovic S. Mediterranean diet in healthy lifestyle and prevention of stroke. Acta Clin Croat 2011, 50:67-77.
23. Meydani M., Hasan S.T. Dietary polyphenols and obesity. Nutrients 2010, 2:737-751.
24. Gil M.I., Tomas-Barberan F.A., Hess-Pierce B., Kader A.A. Antioxidant capacities, phenolic compounds, carotenoids, and vitamin C contents of nectarine, peach, and plum cultivars from California. J Agric Food Chem 2002, 50:4976-4982.
25. Tomas-Barberan F.A., Gil M.I., Cremin P., Waterhouse A.L., Hess-Pierce B., Kader A.A. HPLC-DAD-ESIMS analysis of phenolic compounds in nectarines, peaches, and plums. J Agric Food Chem 2001, 49:4748-4760.
26. Panickar K.S. Effects of dietary polyphenols on neuroregulatory factors and pathways that mediate food intake and energy regulation in obesity. Mol Nutr Food Res 2013, 57:34-47.
27. Zern T.L., Fernandez M.L. Cardioprotective effects of dietary polyphenols. J Nutr 2005, 135:2291-2294.
28. Miller G.L. Use of dinitrosalicylic acid reagent for determination of reducing sugar. Anal Chem 1959, 31:426-428.
29. Swain T., Hillis W. The phenolic constituents of Prinus domestica. I. The Quantitative analysis of phenolic constituents. J Sci Food Agric 1959, 10:63-68.
30. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974, 249:7130-7139.
31. Noratto G.D., Angel-Morales G., Talcott S.T., Mertens-Talcott S.U. Polyphenolics from acai (Euterpe oleracea Mart.) and red muscadine grape (Vitis rotundifolia) protect human umbilical vascular endothelial cells (HUVEC) from glucose- and lipopolysaccharide (LPS)-induced inflammation and target microRNA-126. J Agric Food Chem 2011, 59:7999-8012.
32. Hettinger A.M., Allen M.R., Zhang B.R., Goad D.W., Malayer J.R., Geisert R.D. Presence of the acute phase protein, bikunin, in the endometrium of gilts during estrous cycle and early pregnancy. Biol Reprod 2001, 65:507-513.
33. Miyazaki K., Makino K., Iwadate E., Deguchi Y., Ishikawa F. Anthocyanins from purple sweet potato Ipomoea batatas cultivar Ayamurasaki suppress the development of atherosclerotic lesions and both enhancements of oxidative stress and soluble vascular cell adhesion molecule-1 in apolipoprotein E-deficient mice. J Agric Food Chem 2008, 56:11485-11492.
34. Wang Z., Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm 2010, 2010:535918.
35. Kopff B., Jegier A. Adipokines: adiponectin, leptin, resistin and coronary heart disease risk. Przegl Lek 2005, 62(Suppl. 3):69-72.
36. Jalil A.M., Ismail A., Pei C.P., Hamid M., Kamaruddin S.H. Effects of cocoa extract on glucometabolism, oxidative stress, and antioxidant enzymes in obese-diabetic (Ob-db) rats. J Agric Food Chem 2008, 56:7877-7884.
37. Navab M., Gharavi N., Watson A.D. Inflammation and metabolic disorders. Curr Opin Clin Nutr Metab Care 2008, 11:459-464.
38. Iozzo P. Metabolic toxicity of the heart: insights from molecular imaging. Nutr Metab Cardiovasc Dis 2010, 20:147-156.
39. Noeman S.A., Hamooda H.E., Baalash A.A. Biochemical study of oxidative stress markers in the liver, kidney and heart of high fat diet induced obesity in rats. Diabetol Metab Syndr 2011, 3:17.
40. Huang T.H., Yang Q., Harada M., Li G.Q., Yamahara J., Roufogalis B.D., et al. Pomegranate flower extract diminishes cardiac fibrosis in Zucker diabetic fatty rats: modulation of cardiac endothelin-1 and nuclear factor-kappaB pathways. J Cardiovasc Pharmacol 2005, 46:856-862.
41. Golias C., Tsoutsi E., Matziridis A., Makridis P., Batistatou A., Charalabopoulos K. Review. Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease. In Vivo 2007, 21:757-769.
42. Zakynthinos E., Pappa N. Inflammatory biomarkers in coronary artery disease. J Cardiol 2009, 53:317-333.
43. Boisvert W.A. Modulation of atherogenesis by chemokines. Trends Cardiovasc Med 2004, 14:161-165.
44. Al-Hazimi A.M., Syiamic A.Y. Relationship between plasma angiotensin II, leptin and arterial blood pressure. Saudi Med J 2004, 25:1193-1198.
45. Kurukulasuriya L.R., Stas S., Lastra G., Manrique C., Sowers J.R. Hypertension in obesity. Med Clin North Am 2011, 95:903-917.
46. Touyz R.M., Schiffrin E.L. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications. Vascul Pharmacol 2006, 45:19-28.
47. Seymour E.M., Tanone I.I., Urcuyo-Llanes D.E., Lewis S.K., Kirakosyan A., Kondoleon M.G., et al. Blueberry intake alters skeletal muscle and adipose tissue peroxisome proliferator-activated receptor activity and reduces insulin resistance in obese rats. J Med Food 2011, 14:1511-1518.
48. Dresslerova I., Vojacek J. Diabetes mellitus and ischemic heart disease. Vnitr Lek 2010, 56:301-306.
49. Graf B.L., Raskin I., Cefalu W.T., Ribnicky D.M. Plant-derived therapeutics for the treatment of metabolic syndrome. Curr Opin Investig Drugs 2010, 11:1107-1115.
50. Utsunomiya H., Yamakawa T., Kamei J., Kadonosono K., Tanaka S. Anti-hyperglycemic effects of plum in a rat model of obesity and type 2 diabetes, Wistar fatty rat. Biomed Res 2005, 26:193-200.
51. Park C.H., Jeong S.J., Lee H.J., Lee E.O., Bae H., Lee M.H., et al. Traditional medicine Taeeumjowitangkagambang exerts antiobesity and hypolipidemic effects via antioxidant enzyme enhancement. Phytother Res 2010, 24:1700-1709.
52. Yurt B., Celik I. Hepatoprotective effect and antioxidant role of sun, sulphited-dried apricot (Prunus armeniaca L.) and its kernel against ethanol-induced oxidative stress in rats. Food Chem Toxicol 2011, 49:508-513.
53. Choi C.S., Chung H.K., Choi M.K., Kang M.H. Effects of grape pomace on the antioxidant defense system in diet-induced hypercholesterolemic rabbits. Nutr Res Pract 2010, 4:114-120.
54. Broekhuizen L.N., van Wijk D.F., Vink H., Stalmach A., Crozier A., Hutten B.A., et al. Reduction of monocyte chemoattractant protein 1 and macrophage migration inhibitory factor by a polyphenol-rich extract in subjects with clustered cardiometabolic risk factors. Br J Nutr 2011, 106:1416-1422.
55. Gordon J.W., Shaw J.A., Kirshenbaum L.A. Multiple facets of NF-kappaB in the heart: to be or not to NF-kappaB. Circ Res 2011, 108:1122-1132.
56. Hoffmann A., Levchenko A., Scott M.L., Baltimore D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 2002, 298:1241-1245.
57. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-126.
58. Walcher D., Marx N. Insulin resistance and cardiovascular disease: the role of PPARgamma activators beyond their anti-diabetic action. Diab Vasc Dis Res 2004, 1:76-81.
59. Ginsberg H.N., Huang L.S. The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis. J Cardiovasc Risk 2000, 7:325-331.
60. Chen Z.Y., Jiao R., Ma K.Y. Cholesterol-lowering nutraceuticals and functional foods. J Agric Food Chem 2008, 56:8761-8773.
61. Ansari J.A., Bhandari U., Haque S.E., Pillai K.K. Enhancement of antioxidant defense mechanism by pitavastatin and rosuvastatin on obesity-induced oxidative stress in Wistar rats. Toxicol Mech Methods 2012, 22:67-73.
62. Tsuda T., Horio F., Uchida K., Aoki H., Osawa T. Dietary cyanidin 3-O-beta-d-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J Nutr 2003, 133:2125-2130.
63. Yang X., Yang L., Zheng H. Hypolipidemic and antioxidant effects of mulberry (Morus alba L.) fruit in hyperlipidaemia rats. Food Chem Toxicol 2010, 48:2374-2379.
64. Xia X., Ling W., Ma J., Xia M., Hou M., Wang Q., et al. An anthocyanin-rich extract from black rice enhances atherosclerotic plaque stabilization in apolipoprotein E-deficient mice. J Nutr 2006, 136:2220-2225.
65. Grace M.H., Ribnicky D.M., Kuhn P., Poulev A., Logendra S., Yousef G.G., et al. Hypoglycemic activity of a novel anthocyanin-rich formulation from lowbush blueberry, Vaccinium angustifolium Aiton. Phytomedicine 2009, 16:406-415.
66. Jayaprakasam B., Olson L.K., Schutzki R.E., Tai M.H., Nair M.G. Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas). J Agric Food Chem 2006, 54:243-248.
67. Prior R.L., E Wilkes S., R Rogers T., Khanal R.C., Wu X., Howard L.R. Purified blueberry anthocyanins and blueberry juice alter development of obesity in mice fed an obesogenic high-fat diet. J Agric Food Chem 2010, 58:3970-3976.
68. Unger R.H., Clark G.O., Scherer P.E., Orci L. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 1801, 2010:209-214.
69. Lee R.K., Hittel D.S., Nyamandi V.Z., Kang L., Soh J., Sensen C.W., et al. Unconventional microarray design reveals the response to obesity is largely tissue specific: analysis of common and divergent responses to diet-induced obesity in insulin-sensitive tissues. Appl Physiol Nutr Metab 2012, 37:257-268.
70. Souza M.R., Diniz Mde F., Medeiros-Filho J.E., Araujo M.S. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arq Gastroenterol 2012, 49:89-96.
71. Ikeda U., Matsui K., Murakami Y., Shimada K. Monocyte chemoattractant protein-1 and coronary artery disease. Clin Cardiol 2002, 25:143-147.
72. Duan S.Z., Usher M.G., Mortensen R.M. PPARs: the vasculature, inflammation and hypertension. Curr Opin Nephrol Hypertens 2009, 18:128-133.
73. Lapointe A., Couillard C., Lemieux S. Effects of dietary factors on oxidation of low-density lipoprotein particles. J Nutr Biochem 2006, 17:645-658.
74. Frei B. On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction. Proc Soc Exp Biol Med 1999, 222:196-204.
75. Hope S.A., Meredith I.T. Cellular adhesion molecules and cardiovascular disease. Part II. Their association with conventional and emerging risk factors, acute coronary events and cardiovascular risk prediction. Intern Med J 2003, 33:450-462.
76. Oyekan A. PPARs and their effects on the cardiovascular system. Clin Exp Hypertens 2011, 33:287-293.
77. Sharma A.M., Staels B. Review: peroxisome proliferator-activated receptor gamma and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab 2007, 92:386-395.
78. Romacho T., Elsen M., Rohrborn D., Eckel J. Adipose tissue and its role in organ crosstalk. Acta Physiol 2014, 210:733-753.